Attached files
| file | filename |
|---|---|
| 8-K - INTELLICELL BIOSCIENCES, INC. FORM 8-K - Intellicell Biosciences, Inc. | form8k.htm |
EXHIBIT 16.1
Rosen Seymour Shapss Martin & Company LLP
757 Third Avenue
New York, New York 10017
July 7, 2014
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
We have read the statements that we understand Intellicell Biosciences, Inc. will include under Item 4.01 of the Form 8-K report it will file with the Securities and Exchange Commission regarding the recent change of auditors. We agree with such statements made regarding our firm. We have no basis to agree or disagree with the other statements made under Item 4.0 1.
Very truly yours,
/s/Rosen Seymour Shapss Martin & Company LLP
Rosen Seymour Shapss Martin & Company LLP
Certified Public Accountants